Trial Profile
Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Rosuvastatin
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 13 Dec 2015 New trial record